Clinical trials
Phase 2 Hepatitis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 2 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vir Biotechnology, Inc. | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
| AusperBio Therapeutics Inc. | 1 |
| Gilead Sciences | 1 |
| Intercept Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 7 |
| Digestive System Diseases | 2 |
| Hepatitis B | 2 |
| Hepatitis B, Chronic | 2 |
| Hepatitis C | 2 |
| Hepatitis D | 2 |
| Hepatitis D, Chronic | 2 |
| Liver Diseases | 2 |
| Blood-Borne Infections | 1 |
| Chronic Disease | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.